Evaluation of off-label rapamycin use to promote healthspan in 333 adults

Rapamycin (sirolimus) is an FDA-approved drug with immune-modulating and growth-inhibitory properties. Preclinical studies have shown that rapamycin extends lifespan and healthspan metrics in yeast, invertebrates, and rodents. Several physicians are now prescribing rapamycin off-label as a preventat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaeberlein, Tammi L., Green, Alan S., Haddad, George, Hudson, Johnny, Isman, Anar, Nyquist, Andy, Rosen, Bradley S., Suh, Yousin, Zalzala, Sajad, Zhang, Xingyu, Blagosklonny, Mikhail V., An, Jonathan Y., Kaeberlein, Matt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187519/
https://www.ncbi.nlm.nih.gov/pubmed/37191826
http://dx.doi.org/10.1007/s11357-023-00818-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187519/
https://www.ncbi.nlm.nih.gov/pubmed/37191826
http://dx.doi.org/10.1007/s11357-023-00818-1

Ejemplares similares